Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
12001
NBCe1 protein expression regulation by D<sub>1</sub>-like (D<sub>1</sub>R and D<sub>5</sub>R) dopamine receptor agonist in hRPTCs carrying wild-type (WT) <i>SLC4A5</i>.
Published 2018“…<p>NBCe1 protein expression is decreased following an increase in intracellular sodium (↑Na<sup>+</sup>) (10 μmol monensin/L, 24 h) (N = 4, *P<0.001 vs VEH, one-way ANOVA, Tukey’s test) in WT <i>SLC4A5</i> hRPTC. …”
-
12002
Dopamine decreases the refractive power in the lens periphery.
Published 2013“…Positive ΔBCD values indicate a decrease in refractive power <i>i.e.</i> an increase in BCD in the treated lens compared with the corresponding control lens from the same animal. …”
-
12003
-
12004
Serotonin Receptor 2C and Insulin Secretion
Published 2013“…However, it is known that the 5-HT receptor 2C (5-HT<sub>2C</sub>R) agonist, mCPP, decreases plasma insulin concentration in mice. …”
-
12005
-
12006
-
12007
-
12008
Data_Sheet_2_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu...
Published 2022“…Artesunate normalized paclitaxel-related expression changes in DRG mGluR5, NR1, and GluA2, as well as six paclitaxel related neuroinflammation markers. …”
-
12009
Data_Sheet_1_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu...
Published 2022“…Artesunate normalized paclitaxel-related expression changes in DRG mGluR5, NR1, and GluA2, as well as six paclitaxel related neuroinflammation markers. …”
-
12010
Data_Sheet_6_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu...
Published 2022“…Artesunate normalized paclitaxel-related expression changes in DRG mGluR5, NR1, and GluA2, as well as six paclitaxel related neuroinflammation markers. …”
-
12011
Data_Sheet_3_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu...
Published 2022“…Artesunate normalized paclitaxel-related expression changes in DRG mGluR5, NR1, and GluA2, as well as six paclitaxel related neuroinflammation markers. …”
-
12012
Data_Sheet_4_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu...
Published 2022“…Artesunate normalized paclitaxel-related expression changes in DRG mGluR5, NR1, and GluA2, as well as six paclitaxel related neuroinflammation markers. …”
-
12013
-
12014
-
12015
-
12016
Release-decreasing vs. release-increasing astrocytes.
Published 2011“…The global change of the amount of released resources is accompanied also by local changes in terms of paired-pulse plasticity. (<b>C</b>) For the depressing synapse with release-decreasing astrocyte in (<b>A</b>), the ratio between facilitated (PPF) and depressed (PPD) spike pairs, increases in favor of the former. …”
-
12017
Table_2_Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico.docx
Published 2022“…Our analysis suggests that the vaccination strategy in Mexico has been successful to limit population mortality and decrease severe COVID-19, but children in Mexico still need access to SARS-CoV-2 vaccines to limit severe COVID-19, in particular those 1–4 years old.…”
-
12018
Table_1_Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico.docx
Published 2022“…Our analysis suggests that the vaccination strategy in Mexico has been successful to limit population mortality and decrease severe COVID-19, but children in Mexico still need access to SARS-CoV-2 vaccines to limit severe COVID-19, in particular those 1–4 years old.…”
-
12019
-
12020
<sup>13</sup>C NMR spectra for Kylo-0603.
Published 2025“…Additionally, it effectively lowers serum cholesterol levels by as much as 69.2% and low-density lipoprotein cholesterol (LDL-C) levels by up to 88.2% in the MASH mouse model. …”